• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Pharma & Human Health

Novel Technologies for Understanding Metabolomic Communications between Host and Microbiota

August 9, 2019 Microbiome Times

Webinar Presentation by Alex Buko, Vice President Business and Product Development at Human Metabolome Technologies America.

Pharma & Human Health

Precision editing of gut bacteria reduces cancer in mice

August 7, 2019 Microbiome Times

UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice. The study published this week by the Journal of Experimental Medicine could lay the […]

Finance

LUCA Biologics Launches to Develop Live Biotherapeutics for Women’s Health Starting with UTI

August 7, 2019 Microbiome Times

LUCA Biologics, a biotechnology company co-founded by Dr. Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women’s health. Ravel will serve as LUCA’s Chief Scientist. The company’s first […]

Pharma & Human Health

New Study Finds Multi-Strain Probiotic Aids Dietary Management of Cirrhosis Patients

July 31, 2019 Microbiome Times

A new study published in the peer-reviewed journal Hepatology Communications finds that the multi-strain De Simone Formulation probiotic medical food may help in the dietary management of dysbiosis associated with cirrhosis by improving cognitive function, […]

Pharma & Human Health

Conference Report: 6th Microbiome Business & Collaboration Forum Europe

July 31, 2019 Nina Vinot

The Microbiome Congress in May in Rotterdam brought together three conferences: the 6th Microbiome forum, the 3rd Probiotics Congress and the Skin Microbiome and Cosmeceuticals congress, running in parallel. For this reason this report can’t […]

Pharma & Human Health

Mouse genetics influences the microbiome more than environment

July 29, 2019 Microbiome Times

Genetics has a greater impact on the microbiome than maternal birth environment, at least in mice, according to a study published this week in Applied and Environmental Microbiology. Vaginal birth, known to transfer microbiota to […]

Pharma & Human Health

3D printed pill samples gut microbiome to aid diagnosis and treatment

July 25, 2019 Microbiome Times

A research team led by Tufts University engineers has developed a 3D printed pill that samples bacteria found in the gut — known as the microbiome — as it passes through the gastrointestinal tract (GI). […]

Pharma & Human Health

Keeping livestock in the yard just might help your baby’s immune system

July 24, 2019 Microbiome Times

Getting up close – and a little dirty – with farm animals just might help us fend off illness, say researchers who’ve further demonstrated the benefits of early exposure to a wide variety of environmental […]

Pharma & Human Health

Swedish MPA approves First in Human trial of Ilya Pharma’s first-in-class ILP100 topical wound care therapy 

July 19, 2019 Microbiome Times

Ilya Pharma developing advanced biologics announced that a first in human trial for its lead candidate ILP100 has been approved by the Swedish Medical Products Agency. ILP100 is based on genetically engineered lactic acid bacteria […]

Finance

Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections

July 18, 2019 Microbiome Times

Pherecydes Pharma and BIOASTER, the French Technology Research Institute (TRI) for Microbiology and Infectious Diseases, announced the signing of a collaboration agreement. This project, called PhagUTI, is a unique opportunity for the partners to capitalize […]

Finance

Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.

July 17, 2019 Microbiome Times

Chardan Healthcare Acquisition Corp. (NYSE: CHAC, “CHAC”), a special purpose acquisition company (“SPAC”) sponsored by affiliates of Chardan Capital Markets LLC (“Chardan”), announced today that it has entered into a definitive agreement for a business […]

Posts navigation

« 1 … 57 58 59 … 85 »

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter